Bech-Bruun comfortably holds its position in tier two for patent and trade mark contentious work. Competitors rate the firm highly, especially in patent litigation. In 2010, the firm was involved in pharmaceutical patent infringement litigation case BASF v Makhteshim-Agan. Partner Klaus Ewald Madsen was also active in litigation related to generic pharmaceutical products. Competitors highly rate Madsen for his litigation skills.